Skip to content

Advertisement

BMC Pulmonary Medicine

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Nutritional parameters affecting severity of pneumonia and length of hospital stay in patients with pneumococcal pneumonia: a retrospective cross-sectional study

BMC Pulmonary Medicine201515:149

https://doi.org/10.1186/s12890-015-0143-7

Received: 29 June 2015

Accepted: 18 November 2015

Published: 25 November 2015

Abstract

Background

Pneumococcal pneumonia is the most common form of community-acquired pneumonia (CAP). Although a pneumococcal conjugate vaccine has contributed to a reduction in the incidence of pneumococcal pneumonia among older children and adults, no significant decrease in the incidence has been observed among persons aged ≥65 years. A low body mass index and hypoalbuminemia are common in Japanese patients with CAP, but the association of other nutritional parameters with the severity of pneumonia or length of hospital stay in patients with pneumococcal pneumonia is unclear.

Methods

Fifty-seven previously healthy inpatients who presented with pneumococcal pneumonia were divided into two groups: those aged ≥65 years (n = 36) and those aged <65 years (n = 21). Patients’ characteristics (the Confusion, Urea, Respiratory rate, Blood pressure, age >65 years (CURB-65) score), the pneumonia severity index (PSI), and inflammatory and metabolic nutritional parameters were compared between the two groups.

Results

The older group showed significantly lower serum albumin and cholinesterase (ChE) levels. Multivariate linear regression analysis revealed that the PSI was positively correlated with age in both groups. In the younger age group, both the CURB-65 score and PSI showed significant negative correlations with the serum ChE level, and there was a significant negative correlation between the length of stay and serum total cholesterol (T-cho) level. In the older group, the fasting period, lymphocyte count, and age showed significant positive correlations with the length of stay. There was a significant negative correlation between the length of stay and serum albumin level, but no correlation with the serum ChE or T-cho levels, in the older patients.

Conclusions

Our findings suggest that in patients aged <65 years, age and serum ChE and T-cho levels were associated with both the severity of pneumococcal pneumonia and length of stay. In contrast, the length of stay in older patients was associated with multiple factors that differed from those in younger patients. These differences may reflect age-related immunosenescence in older patients and a greater effect of serum ChE and T-cho levels on immunity in younger patients.

Keywords

CURB-65NutritionLength of stayPneumococcal pneumoniaPneumonia severity index

Background

Streptococcus pneumoniae (pneumococcus) is the most common cause of community-acquired pneumonia (CAP) [1]. The mortality rate of pneumococcal pneumonia is approximately 12 % and has not dramatically changed in the past 50 years despite medical advances [2]. A pneumococcal conjugate vaccine has contributed to a reduction in the incidence of disease among older children and adults [35]; however, no significant decrease in the incidence of invasive pneumococcal disease has been observed among persons aged >64 years [5]. Age of ≥65 years is also an independent predictive factor for in-hospital mortality of patients with CAP [6], and risk scores for patients with CAP, such as the Confusion, Urea, Respiratory rate, Blood pressure, age >65 years (CURB-65) score and pneumonia severity index (PSI), set a high value for age in patients with CAP [6, 7]. Moreover, the incidence of CAP tends to increase with age among people aged ≥65 years [8]. Age was reported to be significantly associated with in-hospital death only in patients with CAP aged >85 years with chronic obstructive disease, and a patient age of 65 to 84 years showed no association with in-hospital death [9]. This suggests that factors other than age itself, but that depend on age, are associated with CAP severity in patients ≥65 years old. A recent study reported a higher frequency of a low body mass index (BMI) (<18.0 kg/m2) and hypoalbuminemia (≤3.5 g/dL) in older Japanese patients with CAP than in control participants and found that hypoalbuminemia was associated with a significantly increased risk of pneumonia [10]. These finding suggest that malnutrition may be an important risk factor for CAP. Another study revealed that physical activity, nutritional status, and dehydration were significant prognostic factors in very old patients with pneumonia [11]. Moreover, in patients with CAP, a low serum albumin level (≤3.0 g/dL) and a low BMI during hospitalization were associated with death from pneumonia during a follow-up period after discharge [12]. However, these studies included patients with aspiration pneumonia or pneumonia resulting from bacteria other than S. pneumonia [8, 12]. The primary objectives of this study were to examine the differences in metabolic nutritional parameters between patients aged ≥65 and <65 years with pneumococcal pneumonia and to elucidate the association between metabolic nutritional parameters and the severity of pneumococcal pneumonia at admission and during hospitalization.

Methods

Study design and population

In total, 134 consecutive patients (52 male, 82 female) who were admitted to the Department of Internal Medicine in our hospital for the treatment of pneumococcal pneumonia from April 2009 to March 2014 were retrospectively identified in our departmental database. Diagnosis of pneumococcal pneumonia was confirmed by (i) detection of S. pneumoniae from a sputum culture, (ii) detection of S. pneumonia antigen in urine, or (iii) findings suggestive of bacterial pneumonia on imaging modalities such as X-ray and computed tomography.

Of these patients, 57 (21 male, 36 female) who had no remarkable medical history (including pneumococcus vaccination), were taking no medications, showed good activities of daily living, and had a full Functional Independence Measure (FIM) score were included in this study. None of the patients enrolled in this study needed mechanical ventilation support. All patients could be discharged from our hospital with a full FIM score and with no sequelae.

The study was conducted in accordance with the Declaration of Helsinki and approved by the Gunma Chuo Hospital Ethics Committee. Written informed consent for inclusion in the study was obtained from all enrolled patients.

Clinical and laboratory findings

Patients were divided into two groups according to their age upon admission: those ≥65 years old (n = 36; age range, 65–90 years) and those <65 years old (n = 21; age range, 20–64 years). The mean age, sex ratio, BMI, CURB-65 score, and PSI were compared between these two groups. The CURB-65 is a scoring system that predicts mortality in patients with CAP [6]. The PSI is also a useful clinical tool for medical practitioners to calculate the probability of morbidity and mortality among patients with CAP [7]. The numbers of patients diagnosed with severe pneumonia (CURB-65 score of ≥4 and/or PSI of >130) were compared between the two groups. Inflammatory parameters (white blood cell count and serum C-reactive protein level) and metabolic nutritional parameters (lymphocyte count and serum levels of albumin [Alb], total cholesterol [T-cho], and cholinesterase [ChE]) [13, 14] were also compared between the two groups. Whole blood and plasma samples were obtained soon after admission.

Antibiotic therapy and nutritional support

The patients were given antibiotic treatment in accordance with the 2005 guidelines for the management of CAP in adults provided by the Japanese Respiratory Society [15], the validity of which was proven in 2012 by a nationwide study in Japan [16]. The guideline committee recommended intravenous administration of high-dose penicillin, ceftriaxone, fourth-generation cephalosporins, carbapenems, or vancomycin for initial treatment of inpatients with pneumococcal pneumonia. In this study, the attending physicians chose a intravenous antibiotic, including high-dose aminobenzylpenicillin (6–8 g/day), ceftriaxone (2 g/day), or meropenem (2 g/day), which are frequently prescribed for primary treatment of CAP in our hospital. None of the enrolled patients were treated with oral or intravenous corticosteroids.

On the day of admission, all patients received peripheral parenteral nutrition (PPN) with intravenous infusion of both lactated Ringer’s solution (500 mL/day) and BFLUID (500 mL/day) (Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan). BFLUID is an infusion preparation with an energy concentration of 4.2 kcal/mL, a pH of 6.7, and an osmotic pressure ratio of 3.0. It includes sugar (10.7 % w/v), amino acids, electrolytes, and vitamin B1, but no fat emulsion. From the second day of admission onward, the dose of intravenous nutrition infusion was readjusted to a maximum of 1000 mL/day in patients who were unable to eat enough food. The addition of BFLUID infusion to the usual lactated Ringer’s solution was determined by the attending physician. PPN with BFLUID was terminated when patients could eat more than half of their meals. Differences in the length of hospital stay, fasting period, duration of PPN, caloric intake by oral ingestion or PPN, types of antibiotics selected, and duration of antibiotic administration were compared between the two age groups. Correlations between length of stay and independent variables including age, inflammatory parameters, metabolic nutritional parameters, fasting period, oral or parenteral caloric intake, PPN duration, CURB-65 score, and PSI were investigated. Multivariate stepwise linear regression analysis was also performed to determine the factors associated with length of stay.

Statistical analysis

Continuous data are presented as mean ± standard deviation or n (%). Comparisons of the admission data between the two age groups were performed using the unpaired t test for parametric data and the Mann–Whitney U test for nonparametric data. Nonparametric data, such as numbers of patients, were compared between the two groups using the χ2 test. Pearson’s correlation coefficient was used to analyze correlations between the CURB-65 score or PSI and independent variables, including age, BMI, and metabolic nutritional parameters (lymphocyte count and serum Alb, T-cho, and ChE levels). Similarly, Pearson’s correlation coefficient was used to analyze correlations between length of stay and independent variables including age, nutritional status parameters, fasting period, oral or parenteral caloric intake, PPN duration, CURB-65 score, and PSI. A P-value of <0.05 was considered to indicate a statistically significant association in the univariate analysis. Multivariate stepwise regression analysis was then performed to specify the independent variables showing a significant association with the CURB-65 score and PSI on admission as well as the length of stay in both groups. Basically, independent variables with a P-value of <0.1 in the univariate analysis were chosen for the multivariate analysis. Multicollinearity was assessed using the variance inflation factor. A variance inflation factor of >10 indicates serious multicollinearity, and a value of >4 may be a cause for concern. The variables that were found to be significantly or closely associated in the univariate analyses were included in the multivariate stepwise linear regression analyses, with P < 0.05 considered statistically significant. All analyses were performed using IBM SPSS Statistics for Windows, version 21.0 J (IBM Corp., Armonk, NY, USA). Datasets used for statistical analysis could not be published because Gunma Chuo Hospital Ethics Committee prohibits release of individual data to the public.

Results

The characteristics of the patients in the two age groups are shown in Table 1. There were no significant differences in the sex ratio or BMI between the two groups. Interestingly, both groups showed a low BMI. In particular, the BMI in the ≥65-year-old group was nearly the lower limit of normal (18.5 kg/m2) [17]. The CURB-65 score was significantly higher in the older group than in the younger group (1.9 ± 0.9 vs 0.5 ± 0.9, respectively; P < 0.001), as was the PSI (105.6 ± 24.5 vs 28.2 ± 46.2, respectively; P < 0.001). The proportion of patients who presented with severe pneumonia was higher in the older group (25 % vs 5 %, respectively), but the difference between the two groups did not reach statistical significance (P = 0.052). Among the inflammatory and metabolic nutritional parameters, the older group had significantly lower levels of serum Alb (3.27 ± 0.59 vs 3.76 ± 0.64 g/dL, respectively; P = 0.005) and ChE (189.8 ± 54.3 vs 237.0 ± 78.1 U/L, respectively; P = 0.010).
Table 1

Comparison of patient characteristics and inflammatory and nutritional parameters between the ≥65- and <65-year-old groups

 

≥65 years (n = 36)

<65 years (n = 21)

P-value

Patients’ characteristics

   

 Mean age (years)

80.1 ± 7.7

44.5 ± 13.9

<0.001*

 Sex (male/female)

13/23

12/9

0.123

 Body mass index (kg/m2)

18.7 ± 4.1

19.6 ± 2.1

0.284

 CURB-65 score on admission

1.9 ± 0.9

0.5 ± 0.9

<0.001*

 PSI on admission

105.6 ± 24.5

28.2 ± 46.2

<0.001*

Inflammatory parameters

   

 White blood cell count (/mm3)

12,750 ± 6490

13,300 ± 5460

0.744

 C-reactive protein (mg/dL)

12.57 ± 11.97

9.60 ± 9.56

0.297

Nutritional parameters

   

 Lymphocyte count (/mm3)

1415.6 ± 1211.5

1664.0 ± 531.0

0.378

 Serum albumin (g/dL)

3.27 ± 0.59

3.76 ± 0.64

0.005*

 Total cholesterol (mg/dL)

167.5 ± 49.7

170.3 ± 43.5

0.833

 Serum cholinesterase (IU/L)

189.8 ± 54.3

237.0 ± 78.1

0.010*

CURB-65 confusion, urea, respiratory rate, blood pressure, age >65 years, PSI pneumonia severity index

*Statistically significant (P < 0.05)

Correlation between CURB-65 score or PSI and independent variables on admission

The CURB-65 score on admission in the older group showed no significant correlations among the independent variables, including age, BMI, and metabolic nutritional parameters (Table 2A). The CURB-65 score in the younger group was significantly correlated with the age of the patients. The PSI on admission was significantly correlated with patient age in both groups (Table 2B).
Table 2

Correlation between CURB-65 score/PSI and independent variables including age, body mass index, and nutritional parameters

A. Univariate analysis of correlations between CURB-65 score and independent variables

Independent variables

≥65 years (n = 36)

<65 years (n = 21)

 Age

0.235 (0.167)

0.463 (0.034*)

 Body mass index

−0.025 (0.883)

−0.210 (0.361)

 Lymphocyte count

−0.164 (0.338)

−0.197 (0.392)

 Serum albumin

−0.249 (0.142)

0.015 (0.948)

 Total cholesterol

−0.248 (0.146)

−0.270 (0.237)

 Serum cholinesterase

−0.122 (0.477)

−0.424 (0.056)

B. Univariate analysis of correlations between PSI and independent variables

Independent variables

≥65 years (n = 36)

<65 years (n = 21)

 Age

0.467 (0.004*)

0.640 (0.002*)

 Body mass index

−0.084 (0.627)

−0.012 (0.958)

 Lymphocyte count

−0.263 (0.122)

−0.145 (0.531)

 Serum albumin

−0.156 (0.365)

−0.076 (0.744)

 Total cholesterol

−0.287 (0.089)

−0.016 (0.946)

 Serum cholinesterase

−0.148 (0.388)

−0.367 (0.102)

*P < 0.05. Data are presented as correlation coefficient (P-value)

Multivariate stepwise linear regression analysis was then carried out to determine the factors associated with the CURB-65 score and PSI in both groups. In the older group, a multivariate regression analysis of the CURB-65 score could not be performed because no independent variable had a P-value of <0.10 in the univariate analysis. The PSI in the older group showed a weak correlation with patient age (correlation coefficient [r] = 0.467, P = 0.004) (Table 3).
Table 3

Correlation between CURB-65 score/PSI and independent variables including age, body mass index, and nutritional parameters

Multivariate linear regression analysis

1. Factors associated with PSI in the ≥65-year-old group (r = 0.467; r 2 = 0.219; adjusted r 2 = 0.196)

 Independent variable

B (95 % CI)

β

t

VIF

P

 Age

1.477 (0.504–2.450)

0.467

3.084

1.000

0.004*

2. Factors associated with CURB-65 score in the <65-year-old group (r = 0.618; r 2 = 0.382; adjusted r 2 = 0.313)

 Independent variables

B (95 % CI)

β

t

VIF

P

 Age

0.030 (0.004–0.056)

0.450

2.429

1.001

0.026*

 Serum cholinesterase

−0.005 (−0.009 to −0.000)

−0.409

−2.208

1.001

0.040*

3. Factors associated with PSI in the <65-year-old group (r = 0.728; r 2 = 0.529; adjusted r 2 = 0.477)

 Independent variables

B (95 % CI)

β

t

VIF

P

 Age

2.096 (0.962–3.229)

0.629

3.886

1.001

0.001*

 Serum cholinesterase

−0.205 (−0.406 to −0.004)

−0.347

−2.142

1.001

0.046*

(r = 0.467; r 2 = 0.219; 2 adjusted r 2 = 0.196)

r multiple correlation coefficient, r 2 coefficient of determination, B nonstandardized regression coefficient, CI confidence interval; β standardized regression coefficient; VIF variance inflation factor.

*P < 0.05

Interestingly, multivariate regression analysis revealed that both the CURB-65 score and PSI in the younger group were correlated with the ChE level, although the absolute value of the standardized regression coefficient (β) of patient age was larger than that of the serum ChE level. Specifically, a weak but significant negative correlation was observed between the CURB-65 score and ChE level (β = −0.409, P = 0.040) and between the PSI and serum ChE level (β = −0.347, P = 0.046).

Clinical course during hospitalization

All patients enrolled in this study were discharged from the hospital with a full FIM score, and no patient had delayed discharge because of social or health issues such as refusal to leave the hospital or the need for additional rehabilitation to recover activities of daily living. None of the patients was readmitted to our hospital within 1 year after discharge. However, the clinical courses during hospitalization differed between the two age groups. Specifically, the hospitalization period was significantly longer in the older than younger group (17.5 ± 12.9 vs 9.0 ± 3.4 days, respectively; P = 0.001) (Table 4). The older group also had a significantly longer fasting period (2.7 ± 7.2 vs 0.2 ± 0.8 days, respectively; P = 0.022), PPN implementation period (8.4 ± 11.4 vs 2.7 ± 2.6 days, respectively; P = 0.014), and antibiotic administration period (8.9 ± 2.6 vs 6.7 ± 2.9 days, respectively; P = 0.002). In addition, caloric intake by oral ingestion was significantly lower in the older group (1357.9 ± 533.1 vs 1652.4 ± 366.5 kcal/day, respectively; P = 0.03), while the PPN caloric intake was significantly higher (266.9 ± 49.4 vs 144.8 ± 153.6 kcal/day, respectively; P = 0.034). Regarding the antibiotics selected for treatment of pneumococcal pneumonia, the proportion of patients prescribed meropenem was significantly higher in the older group.
Table 4

Comparison of clinical course, caloric intake, and selected antibiotics during hospitalization

 

≥65 years (n = 36)

<65 years (n = 21)

P-value

Clinical course during hospitalization

   

 Length of stay (days)

17.5 ± 12.9

9.0 ± 3.4

0.001*

 Fasting period (days)

2.7 ± 7.2

0.2 ± 0.8

0.022*

 Duration of PPN implementation (days)

8.4 ± 11.4

2.7 ± 2.6

0.014*

 Duration of antibiotic administration (days)

8.9 ± 2.6

6.7 ± 2.9

0.002*

Mean caloric intake

   

 Oral ingestion (kcal/day)

1357.9 ± 533.1

1652.4 ± 366.5

0.030*

 PPN (kcal/day)

266.9 ± 49.4

144.8 ± 153.6

0.034*

Selected antibiotics

   

 High-dose ABPC

18

13

0.384

 Ceftriaxone

6

6

0.288

 Meropenem

12

2

0.044*

PPN peripheral parenteral nutrition, ABPC aminobenzylpenicillin

*P < 0.05

Correlations between variables and length of stay

Correlation analysis of factors associated with length of stay revealed interesting results (Table 5). In the younger group, the serum Alb (r = −0.542, P = 0.011), T-cho (r = −0.558, P = 0.009), and ChE levels (r = −0.493, P = 0.023) and the fasting period (r = 0.403, P = 0.023) were significantly correlated with the length of stay. In the older group, the serum Alb (r = −0.527, P = 0.001) and ChE levels (r = −0.516, P = 0.001) and the fasting period (r = 0.567, P < 0.001) showed significant correlations with the length of stay, but the serum T-cho level did not show a significant correlation. In addition, age (r = 0.479, P = 0.003), BMI (r = −0.488, P = 0.003), oral caloric intake (r = −0.445, P = 0.007), and PPN duration (r = 0.832, P < 0.001) showed significant correlations with the length of stay only in the older group. Regarding parameters associated with pneumonia severity, only the CURB-65 score in the younger group showed a significant correlation with length of stay (r = 0.438, P = 0.047).
Table 5

Correlations between length of stay and independent variables in univariate analysis

Independent variables

≥65 years (n = 36)

<65 years (n = 21)

Age

0.479 (0.003*)

−0.062 (0.788)

Body mass index

−0.488 (0.003*)

−0.145 (0.532)

Nutritional parameters

  

 Lymphocyte count

0.305 (0.071)

−0.163 (0.480)

 Serum albumin

−0.527 (0.001*)

−0.542 (0.011*)

 Total cholesterol

0.244 (0.152)

−0.558 (0.009*)

 Serum cholinesterase

−0.516 (0.001*)

−0.493 (0.023*)

Parameters related to nutrition support

  

 Fasting period

0.567 (<0.001*)

0.403 (0.070)

 Oral caloric intake

−0.445 (0.007*)

0.077 (0.740)

 PPN caloric intake

0.163 (0.342)

0.237 (0.301)

 PPN duration

0.832 (<0.001*)

0.115 (0.620)

Parameters associated with pneumonia severity

  

 CURB-65 score

0.295 (0.146)

0.438 (0.047*)

 PSI

0.146 (0.396)

0.282 (0.215)

*P < 0.05. Data are presented as correlation coefficient (P-value)

Multivariate linear regression analysis in the older patients revealed that the fasting period (β = 0.399, P = 0.005), lymphocyte count (β = 0.315, P = 0.012), and age (β = 0.267, P = 0.044) had a significant positive correlation with the length of stay and that only the serum Alb level had a significant negative correlation (β = −0.292, P = 0.024) (Table 6). In younger patients, however, the serum T-cho level (β = −0.558, P = 0.009) was the only significant independent variable and showed a negative correlation with the length of stay.
Table 6

Multivariate stepwise linear regression analysis of factors associated with length of stay

1. Factors associated with length of stay in the ≥65-year-old group (r = 0.778; r 2 = 0.605; adjusted r 2 = 0.554)

Independent variables

B (95 % CI)

β

t

VIF

P

 Fasting period

0.718 (0.239–1.198)

0.399

3.055

1.340

0.005*

 Lymphocyte count

0.003 (0.001–0.006)

0.315

2.680

1.086

0.012*

 Serum albumin

−6.345 (−11.778 to −0.913)

−0.292

−2.382

1.176

0.024*

 Age

0.446 (0.012–0.880)

0.267

2.098

1.086

0.044*

2. Factors associated with hospitalization period in the <65-year-old group (r = 0.558; r 2 = 0.311; adjusted r 2 = 0.275)

 Independent variable

B (95 % CI)

β

t

VIF

P

 Serum total cholesterol

−0.043 (−0.074 to −0.012)

−0.558

3.055

1.000

0.009*

*P < 0.05

Discussion

This study focused on the correlation between nutritional status and disease severity and between nutritional status and length of hospital stay in patients with pneumococcal pneumonia. Interestingly, the mean BMI of both age groups nearly reached the lower limit of normal (18.5 kg/m2). Past studies have shown that a lower BMI is associated with increased mortality among patients with CAP [18, 19] and that a higher BMI is associated with reduced mortality at 30 days after admission in patients with pneumococcal or Haemophilus CAP [20]. In the present study, however, BMI showed no significant correlations with pneumonia severity on admission or length of stay in the multivariate regression analysis in either age group. The most probable reason for this is selection bias resulting from the small number of enrolled patients in this study. Most of the patients had a low BMI, leading to the inability to show a significant association between BMI and pneumonia severity or length of stay.

It is understandable that both the CURB-65 score and PSI on admission were higher in the older than younger group because patient age is a determinant of both scores [6, 7]. The CURB-65 score is commonly used to discriminate severely ill patients, while the PSI has been well validated for the assessment of patients with a low mortality risk [21]. Interestingly, multivariate regression analysis showed significantly negative correlations between the serum ChE level and the pneumonia severity score, including both the CURB-65 score and PSI, only in the younger group. To the best of our knowledge, an association between the serum ChE level and severity of CAP has not been reported previously. These findings suggest that the serum ChE level may indirectly affect the immune response of patients with CAP. Acetylcholine was recently reported to have immunosuppressive effects on macrophages or other immune cells containing the α7 nicotinic acetylcholine receptor by suppressing inflammatory cytokine production [22]. This regulatory pathway mainly involves a link between neurotransmitters in blood and macrophages [22]. Therefore, low serum ChE levels, including both acetylcholinesterase and butyrylcholinesterase, may enhance immunosuppression by accumulation of unhydrolyzed acetylcholine, leading to activation of the cholinergic anti-inflammatory pathway and resultant aggravation of pneumococcal pneumonia [22, 23]. Actually, the use of ChE inhibitors in hospitalized patients with dementia has been suggested to increase the risk of respiratory disease, including pneumonia [24]. However, it should again be noted that there was a significant correlation between patient age and the CURB-65 score/PSI in both age groups in the present study. Advancing age is closely related to weakened integrity of physical barriers as well as low immune responsiveness against invading pathogens because of respiratory tract immunosenescence [25]. In the multivariate analysis, the absence of a significant correlation between independent variables and the PSI (other than age) in the older group may suggest more pronounced effects of immunosenescence on pneumonia severity in older patients with CAP.

Regarding length of stay, only the serum T-cho level showed a significant negative correlation in the younger group in the multivariate regression analysis. Past studies have shown that a lower serum T-cho level is associated with a risk of CAP in young patients [26] and that a low serum high-density lipoprotein cholesterol level may be a poor prognostic factor in patients with severe CAP [27]. Recent studies have revealed that alveolar epithelial type II cells and alveolar macrophages receive cholesterol from circulating high-density and low-density lipoprotein [28]. Alveolar epithelial type II cells also play a pivotal role in alveolar injury repair and homeostatic maintenance [29]. Accordingly, a lower T-cho level may be associated with dysfunction of alveolar epithelial type II cells and alveolar macrophages, slowing the recovery of pneumococcal pneumonia. On the other hand, in the older group, the age, fasting period, and lymphocyte count showed a significant positive correlation with the length of stay, while the serum Alb level was the only independent variable showing a significant negative correlation in the multivariate regression analysis. These results revealed different independent factors associated with length of stay in the two age groups, suggesting that multiple factors related to immunosenescence may affect length of stay in the elderly [25]. Actually, older patients with CAP showed a lower systemic inflammatory response than did younger patients with CAP despite equivalent serum concentrations of proinflammatory cytokines [30]. The number and functions of T lymphocytes also decrease with age, and hypoalbuminemic malnutrition can depress the activities of T lymphocytes [31, 32]. Moreover, fasting can decrease the activities of both mucosal T and B cells in terms of their ability to maintain pulmonary lymphocyte populations and mucosal IgA secretion in the respiratory tract and intestinal mucosa [33, 34]; thus, immune dysfunction resulting from immunosenescence, hypoalbuminemia, or fasting may be associated with a prolonged length of stay in older patients. However, the reason why the lymphocyte count was positively correlated with the length of stay only in the older group in the present study despite the fact that there were no significant differences in the lymphocyte count between the older and younger groups remains unclear. Therefore, further research is required to clarify the functional alterations of lymphocytes in older patients with pneumococcal pneumonia.

Limitations

This study is limited by the relatively small number of patients from a single institution, possible selection bias, and the retrospective cross-sectional design. We mainly used univariate and multivariate linear regression analyses to investigate the association between independent variables and the severity of pneumonia or length of stay. Therefore, the relationship between these variables is unclear. Similarly, the clinical effects of antibiotics on length of stay are unclear. In addition, the associations of serum low-density lipoprotein, high-density lipoprotein, lymphocyte subsets, and objective nutritional parameters with body composition such as lean body mass were not measured. Prospective cohort studies are needed to further explore these interactions.

Conclusions

The severity of pneumococcal pneumonia was most strongly correlated with patient age in both the ≥65- and <65-year-old groups. Notably, in the younger group, the serum ChE level was negatively correlated with the severity of pneumonia and the serum T-cho level was the only independent variable that was negatively correlated with the length of stay. In the older group, the fasting period, lymphocyte count, and age were positively correlated with the length of stay, while the serum Alb level was negatively correlated. These differences may reflect age-related immunosenescence in older patients and the marked effects of the serum ChE and T-cho levels on immunity in younger patients.

Abbreviations

Alb: 

albumin

BMI: 

body mass index

CAP: 

community-acquired pneumonia

ChE: 

cholinesterase

CURB-65: 

Confusion, Urea, Respiratory rate, Blood pressure, age >65 years

FIM: 

Functional Independence Measure

PPN: 

peripheral parenteral nutrition

PSI: 

pneumonia severity index

T-cho: 

total cholesterol

Declarations

Acknowledgments

The authors thank Miss Hisae Kuribara for her secretarial assistance under the financial support funded by Gunma Chuo Hospital.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Nutrition Support Team, Gunma Chuo Hospital, Maebashi, Japan

References

  1. Sanz Herrero F, Blanquer OJ. Microbiology and risk factors for community-acquired pneumonia. Semin Respir Crit Care Med. 2012;33:220–31.View ArticlePubMedGoogle Scholar
  2. Feldman C, Anderson R. Recent advances in our understanding of Streptococcus pneumoniae infection. F1000Prime Rep. 2014;6:82.Google Scholar
  3. Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis. 2011;11:760–8.View ArticlePubMedGoogle Scholar
  4. Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease—United States, 1998–2003. MMWR Morb Mortal Wkly Rep. 2005;54:893–7.Google Scholar
  5. von Gottberg A, de Gouveia L, Tempia S, Quan V, Meiring S, von Mollendorf C, et al. GERM-SA Investigators. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014;371:1889–99.View ArticleGoogle Scholar
  6. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377–82.PubMed CentralView ArticlePubMedGoogle Scholar
  7. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–50.View ArticlePubMedGoogle Scholar
  8. Simonetti AF, Viasus D, Garcia-Vidal C, Carratalà J. Management of community-acquired pneumonia in older adults. Ther Adv Infect Dis. 2014;2:3–16.PubMed CentralPubMedGoogle Scholar
  9. Yamauchi Y, Yasunaga H, Matsui H, Hasegawa W, Jo T, Takami K, et al. Comparison of clinical characteristics between aspiration pneumonia and community-acquired pneumonia in patients with chronic obstructive pulmonary disease. BMC Pulm Med. 2015;15:69.PubMed CentralView ArticlePubMedGoogle Scholar
  10. Washio M, Kondo K, Fujizawa N, Harada E, Tashiro H, Mizokami T, et al.; the Kyushu Task Force for CAP Risk in the Elderly. Hypoalbuminemia, influenza vaccination and other factors related to the development of pneumonia acquired outside hospitals in southern Japan: A case control study. Geriatr Gerontol Int. 2015; doi:10.1111/ggi12456. [Epub ahead of print].
  11. Maruyama T, Gabazza EC, Morser J, Takagi T, D’Alessandro-Gabazza C, Hirohata S, et al. Community-acquired pneumonia and nursing home-acquired pneumonia in the very elderly patients. Respir Med. 2010;104:584–92.View ArticlePubMedGoogle Scholar
  12. Hedlund J. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis. Scand J Infect Dis Suppl. 1995;97:1–60.PubMedGoogle Scholar
  13. Schneider SM, Hebuterne X. Use of nutritional scores to predict clinical outcomes in chronic diseases. Nutr Rev. 2000;58:31–8.View ArticlePubMedGoogle Scholar
  14. Grandone I, Santarpia L, Alfonsi L, Pagano MC, Pasanisi F, Contaldo F. Serum cholinesterase as indicator of parenteral nutrition efficacy in protein energy malnutrition: four case reports. E Spen Eur J Clin Nutr Metab. 2010;5:e6–9.View ArticleGoogle Scholar
  15. Miyashita N, Fukano H, Mouri K, Fukuda M, Yoshida K, Kobashi Y, et al. Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study. J Med Microbiol. 2005;54(Pt 4):395–400.View ArticlePubMedGoogle Scholar
  16. Watanabe A, Goto H, Kohno S, Matsushima T, Abe S, Aoki N, et al. Nationwide study on the 2005 guidelines for the management of community-acquired adult pneumonia: validation of differentiation between bacterial pneumonia and atypical pneumonia. Respir Investig. 2012;50:23–32.View ArticlePubMedGoogle Scholar
  17. BMI classification. Global Database on Body Mass Index. World Health Organization. 2006. http://apps.who.int/bmi/index.jsp?introPage=intro_3.html. Accessed 22 November 2015.
  18. Hedlund J, Hansson LO, Ortqvist A. Short- and long-term prognosis for middle-aged and elderly patients hospitalized with community-acquired pneumonia: impact of nutritional and inflammatory factors. Scand J Infect Dis. 1995;27:32–7.View ArticlePubMedGoogle Scholar
  19. Tejera A, Santolaria F, Diez ML, Aleman-Valls MR, Gonzalez-Reimers E, Martinez-Riera A, et al. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine. 2007;38:117–23.View ArticlePubMedGoogle Scholar
  20. Corrales-Medina VF, Valayam J, Serpa JA, Rueda AM, Musher DM. The obesity paradox in community-acquired bacterial pneumonia. Int J Infect Dis. 2011;15:e54–7.View ArticlePubMedGoogle Scholar
  21. Ateel HC, Cockeran R, Anderson R, Feldman C. Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease. Mediators Inflamm. 2013;2013:490346.Google Scholar
  22. Pohanka M. Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity. Int J Mol Sci. 2014;15:9809–25.PubMed CentralView ArticlePubMedGoogle Scholar
  23. Shenhar-Tsarfaty S, Berliner S, Bornstein NM, Soreg H. Cholinesterases as biomarkers for parasympathetic dysfunction and inflammation-related disease. J Mol Neurosci. 2014;53:298–305.View ArticlePubMedGoogle Scholar
  24. Helou R, Rhalimi M. Cholinesterase inhibitors and the risk of pulmonary disorders in hospitalized dementia patients. J Popul Ther Clin Pharmacol. 2020;17:e379–89.Google Scholar
  25. Meyer KC. The role of immunity and inflammation in lung senescence and susceptibility to infection in the elderly. Semin Respir Crit Care Med. 2010;31:561–74.View ArticlePubMedGoogle Scholar
  26. Kang DR, Kim YK, Park MS, Kim YS, Ko DH, Kim C. Low levels of serum cholesterol and albumin and the risk of community-acquired pneumonia in young soldiers. Int J Tuberc Lung Dis. 2008;12:26–32.PubMedGoogle Scholar
  27. Chien YF, Chen CY, Hsu CL, Chen KY, Yu CJ. Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission. J Crit Care. 2015;30:506–10.View ArticlePubMedGoogle Scholar
  28. Gowdy KM, Fessler MB. Emerging roles for cholesterol and lipoproteins in lung disease. Pulm Pharmacol Ther. 2013;26:430–7.PubMed CentralView ArticlePubMedGoogle Scholar
  29. Garcia O, Hiatt MJ, Lundin A, Lee J, Reddy R, Navarro S, et al. Targeted type 2 alveolar cell depletion provides a dynamic functional model for lung injury. Am J Respir Cell Mol Biol. 2015; Jul 23. [Epub ahead of print]Google Scholar
  30. van Vught LA, Endeman H, Meijvis SC, Zwinderman AH, Scicluna BP, Biesma DH, et al. The effect of age on the systemic inflammatory response in patients with community-acquired pneumonia. Clin Microbiol Infect. 2014;20:1183–8.View ArticlePubMedGoogle Scholar
  31. Bourée P. Immunity and immunization in elderly. Pathol Biol (Paris). 2003;51:581–5.View ArticleGoogle Scholar
  32. Abbott WC, Tayek JA, Bistrian BR, Maki T, Ainsley BM, Reid LA, et al. The effect of nutritional support on T-lymphocyte subpopulations in protein-caloric malnutrition. J Am Coll Nutr. 1986;5:577–84.View ArticlePubMedGoogle Scholar
  33. Hermsen JL, Gomez FE, Sano Y, Kang W, Maeshima Y, Kudsk KA. Parenteral feeding depletes pulmonary lymphocyte populations. JPEN J Parenter Enteral Nutr. 2009;33:535–40.PubMed CentralView ArticlePubMedGoogle Scholar
  34. Wu Y, Kudsk KA, DeWitt RC, Tolley EA, Li J. Route and type of nutrition influence IgA-mediating intestinal cytokines. Ann Surg. 1999;229:662–7.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Akuzawa and Naito. 2015

Advertisement